The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 3, randomized, placebo-controlled clinical trial of CAN-2409+prodrug in combination with standard of care external beam radiation (EBRT) for newly diagnosed localized prostate cancer.
 
Theodore DeWeese
Employment - Johns Hopkins Medicine
Leadership - Johns Hopkins Medicine
Stock and Other Ownership Interests - Digital Harmonic
Patents, Royalties, Other Intellectual Property - patent pending on computer algorithm in radiation therapy planning
 
Thomas Wheeler
Employment - Sagis Diagnostics, PLLC
Stock and Other Ownership Interests - DNA SEQ Alliance
Consulting or Advisory Role - Candel Therapeutics
 
John Sylvester
Stock and Other Ownership Interests - C4 Imaging
Honoraria - Boston scientific
Consulting or Advisory Role - Myriad Pharmaceuticals; Theragenics
Research Funding - Candel Therapeutics
Patents, Royalties, Other Intellectual Property - Rectal balloon design
Travel, Accommodations, Expenses - Jansen publications
 
Thomas Schroeder
No Relationships to Disclose
 
Glen Gejerman
Honoraria - Boston Scientific; Teleflex Medical
Consulting or Advisory Role - Teleflex Medical
Speakers' Bureau - Teleflex Medical
 
Gregory Chesnut
No Relationships to Disclose
 
Thomas Facelle
Stock and Other Ownership Interests - Candel Therapeutics
Research Funding - Astellas Amgen BioPharama; Bayer; Candel Therapeutics; Janssen
 
Mark Garzotto
Research Funding - Advantagene (Inst); Astellas Pharma (Inst); Merck (Inst); Pfizer (Inst); Sesen Bio (Inst); Viventia Biotech (Inst)
 
Ronald Tutrone
Employment - Chesapeake Urology
Stock and Other Ownership Interests - Compass Therapeutics; GlaxoSmithKline; ImmnityBio; Novartis; Urogen pharma; Veru
Consulting or Advisory Role - Exosome Diagnostics; Myovant Sciences; Novartis; Nymox
Speakers' Bureau - Medivation/Astellas; Pfizer
Research Funding - Advantagene (Inst); Arvinas (Inst); AstraZeneca (Inst); Bayer (Inst); Blue Earth Diagnostics (Inst); Dendreon (Inst); ESSA (Inst); Exosome Diagnostics (Inst); Francis Medical (Inst); Genomic Health (Inst); Janssen Oncology (Inst); Lantheus Medical Imaging (Inst); Lilly (Inst); MDxHealth (Inst); Medivation/Astellas (Inst); Merck (Inst); POINT Biopharma (Inst); Propella Therapeutics (Inst)
 
Christopher Pieczonka
Employment - Associated Medical Professionals of New York
Leadership - Associated Medical Professionals of New York; US UROLOGY PARTNERS; US UROLOGY PARTNERS
Stock and Other Ownership Interests - US Urology Partners
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; Janssen; Merck; Myovant Sciences; Novartis; Pfizer/Astellas; Sun Pharma
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; Janssen Oncology; Merck; Novartis; Pfizer/Astellas; Sun Pharma; Sun Pharma; Tolmar
Speakers' Bureau - Astellas Pharma; Astra Zenerca; Bayer; Dendreon; Janssen Oncology; Merck; Myovant Sciences; Pfizer; Sun Pharma
Research Funding - Advantagene; Astellas Pharma; AstraZeneca; Bayer; Candel Therapeutics (Inst); Dendreon; InVitae; InVitae; Janssen Oncology; Merck; Pfizer
 
Megan Goody
Employment - Candel Therapeutics
Stock and Other Ownership Interests - Candel Therapeutics
Research Funding - Candel Therapeutics
Travel, Accommodations, Expenses - Candel Therapeutics
 
Jenessa Vogt
Employment - Candel Therapeutics; Mass General Brigham (I)
Stock and Other Ownership Interests - Candel Therapeutics
 
Shangbang Rao
Employment - Candel Therapeutics
Stock and Other Ownership Interests - Candel Therapeutics
Travel, Accommodations, Expenses - Candel Therapeutics
 
Maria Lucia Silva Polanco
Employment - Candel Therapeutics
Stock and Other Ownership Interests - Candel Therapeutics
 
Andrea Manzanera
Employment - Candel Therapeutics
Stock and Other Ownership Interests - Candel Therapeutics; Candel Therapeutics
 
Francesca Barone
Employment - Candel Therapeutics
Leadership - Candel Therapeutics
Stock and Other Ownership Interests - Candel Therapeutics
Patents, Royalties, Other Intellectual Property - Candel Therapeutics: patents on CAN-2409 mode of use, including for use in prostate cancer. Patents are not giving royalties yet.
 
William Nichols
Employment - Candel Therapeutics; Corner Therapeutics
Leadership - Candel Therapeutics; Corner Therapeutics
Stock and Other Ownership Interests - Candel Therapeutics; Corner Therapeutics
Consulting or Advisory Role - Istari Oncology; Kovina Therapeutics; SymBio Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Patent and patents pending related to Candel's investigational products, CAN-2409 and CAN-3110; Patents and patents pending related to Istari's investigational product, lerapolturev
 
Paul Peter Tak
Employment - Candel Therapeutics
Leadership - Candel Therapeutics
Stock and Other Ownership Interests - Candel Therapeutics
Patents, Royalties, Other Intellectual Property - Candel patents focused on viral immunotherapy